U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07295067) titled 'Extracellular Vesicles for the Treatment of Syringomyelia' on Nov. 19.
Brief Summary: This is a open-label, single-arm, dose escalation phase I clinical trial. The goal of this clinical trial is to evaluate the safety and preliminary efficacy of Intrathecal injection human umbilical cord-derived mesenchymal stromal cell-derived extracellular vesicle (hUC-MSC-sEV) in syringomyelia.
Study Start Date: Dec. 15
Study Type: INTERVENTIONAL
Condition:
Syringomyelia
Intervention:
DRUG: Exosomes group
Exosomes derived from human umbilical cord blood mesenchymal stem cells for Intrathecal injection (administered once a month, for a tota...